Description: SyntekaBio, Inc. operates as a genomic big data and artificial intelligence drug discovery company. It creates new drug candidates using DeepMatcher, an AI drug development platform that combines new drug development technology and genomic big data technology, such as biomarkers for individual cancer drug screening and disease susceptibility by immunotyping, pharmacogenomic typing, and predicting multi-omics information-based drug adverse effects, etc. The company also developing new antigen prediction technology that can be used together with therapeutic vaccines and cell therapy products, and prediction of antibody therapeutics. SyntekaBio, Inc. was founded in 2009 and is headquartered in Daejeon, South Korea.
Home Page: www.syntekabio.com
1903, 1, Expo-ro
Daejeon,
34126
South Korea
Phone:
82 70 7663 0958
Officers
| Name | Title |
|---|---|
| Mr. Jongsun Jung | President & CTO |
| Mr. Brian Noh | Chief Marketing Officer and Vice President of Strategy & Marketing |
| Mr. Joonhyuk Choi | Head of US Operations |
Exchange: KQ
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
| GIC Sector: | Energy |
|---|---|
| GIC Group: | Energy |
| GIC Industry: | Oil, Gas & Consumable Fuels |
| GIC Sub-Industry: | Coal & Consumable Fuels |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.7913 |
| Price-to-Sales TTM: | 652.6248 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 63 |